Acadia Healthcare Company, Inc. $ACHC Shares Acquired by Aberdeen Group plc

Aberdeen Group plc grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 72.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 743,925 shares of the company’s stock after purchasing an additional 312,172 shares during the period. Aberdeen Group plc owned approximately 0.81% of Acadia Healthcare worth $10,556,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of ACHC. EverSource Wealth Advisors LLC grew its stake in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the period. Hantz Financial Services Inc. increased its holdings in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares in the last quarter. Quent Capital LLC acquired a new stake in Acadia Healthcare in the 3rd quarter valued at $71,000. Steward Partners Investment Advisory LLC raised its holdings in shares of Acadia Healthcare by 639.5% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock valued at $77,000 after buying an additional 2,916 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after buying an additional 2,698 shares during the period.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on ACHC shares. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Guggenheim decreased their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. Jefferies Financial Group cut shares of Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Zacks Research raised shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th. Finally, Barclays upped their price objective on shares of Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 3rd. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus target price of $21.15.

Acadia Healthcare Price Performance

Shares of ACHC opened at $25.39 on Wednesday. The firm has a market capitalization of $2.34 billion, a price-to-earnings ratio of -2.08, a price-to-earnings-growth ratio of 8.09 and a beta of 0.71. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $30.17. The stock’s fifty day moving average is $20.20 and its 200-day moving average is $18.86.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The company had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. Acadia Healthcare’s revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.